Clinical Trials Logo

Diabetic Peripheral Neuropathy clinical trials

View clinical trials related to Diabetic Peripheral Neuropathy.

Filter by:

NCT ID: NCT04658693 Recruiting - Clinical trials for Diabetic Peripheral Neuropathy

Functional and Neuroprotective Effects of Restoring Lower Limb Sensation After Diabetic Peripheral Neuropathy

Start date: March 2, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effectiveness of providing sensation of the missing limb to individuals with above and below the knee limb loss. The investigators will implanted stimulating electrodes to send small electrical currents to the remaining nerves. These small electrical currents cause the nerves to generate signals that are then transferred to your brain similar to how the information about your foot and lower limb used to be transferred to the brain prior to your limb loss. Additionally, there is the option to have muscle recording electrodes implanted within the muscles of the lower limb with the goal to develop a motor controller that would allow the user to have intuitive control of a robotic prosthetic leg.

NCT ID: NCT04638556 Recruiting - Clinical trials for Diabetic Peripheral Neuropathy

Effect of Circulating lncRNAs on Type 2 Diabetic Peripheral Neuropathy

Start date: September 3, 2019
Phase:
Study type: Observational

This project intends to use high-throughput sequencing, molecular biology and bioinformatics technology to clarify the role of target lncrnas in the inflammatory response of DPN, to explore the correlation between target lncrnas and DPN pathogenesis, and to clarify the feasibility of target lncrnas as a marker of DPN cycle.

NCT ID: NCT04605900 Completed - Clinical trials for Diabetes Mellitus, Type 2

Impact of Therapeutic Footwear and Plantar Orthoses on Diabetic Neuropathic Foot in Quality of Life and Functionality

Start date: March 13, 2017
Phase: N/A
Study type: Interventional

This study determines the effectiveness of plantar orthoses and custom-made orthopedic footwear in functional level and quality of life of persons with diabetes type 2 and diabetic peripheral neuropathy. This study is important due the loss of protective sensation, feet are vulnerable to minor trauma caused by plantar pressure as well as mechanical and thermal injuries. Thus, Plantar Orthoses become necessary to reduce PP and align the foot. Additionally, it is known that footwear is the most frequent cause of diabetic foot injury, since ulceration is frequently a consequence of the continuous trauma provoked by inadequate footwear. For a higher efficacy in the treatment of the foot, it is also necessary to use custom-made orthopedic footwear, indicated in the treatment of foot pathologies. The lack of studies that evaluate the impact of this treatment on clinical measures such as quality of life and functional level, led to the development of this study, comparing a standard treatment (standard footwear and plantar orthoses) with an optimal treatment suggested in diabetic foot guidelines (therapeutic footwear and plantar orthoses).

NCT ID: NCT04555876 Not yet recruiting - Clinical trials for Diabetic Peripheral Neuropathy

Effect of High Tone External Muscle Stimulation on Peripheral Arterial Disease

Start date: November 1, 2020
Phase: N/A
Study type: Interventional

to investigate the effect of high tone external muscle stimulation (HTEMS) on endothelial dysfunction and walking parameters in peripheral vascular disease.

NCT ID: NCT04543422 Completed - Clinical trials for Diabetic Peripheral Neuropathy

Green Tea Extracts for Mild-to-moderate Diabetic Peripheral Neuropathy

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

the present randomized placebo-controlled study aimed to evaluate the effect of green tea extract administration on the clinical and neurophysiological parameters in patients with mild-to-moderate diabetic peripheral neuropathy.

NCT ID: NCT04543032 Completed - Clinical trials for Diabetic Peripheral Neuropathy

Sensorimotor Training and Gait in Diabetic Polyneuropathy

Start date: January 5, 2021
Phase: N/A
Study type: Interventional

Diabetic peripheral neuropathy is a common chronic complication of diabetes mellitus which results in high public health costs and has a huge impact on patients' quality of life. It leads to sensory and motor deficits, which often result in mobility-related dysfunction, and alterations in gait characteristics. These alternations in gait performance cause increase in the risk of fall, which has the strongest association with symptoms of depression in patients with diabetes. However, little is known about possible treatment strategies for improving gait ability and reduce risk of fall in patients with diabetic neuropathy. So, the purpose of this study will be to investigate the effect of sensorimotor training on ankle muscle strength, gait and quality of life in patients with diabetic peripheral neuropathy. To determine if there is an effect for sensorimotor training on gait, ankle muscle strength and quality of life in patients with diabetic peripheral neuropathy, the patient will be assessed before and after 6 weeks of treatment by measurement of ankle muscles strength using isokinetic dynamometer, measurement of different spatiotemporal gait parameters using gait trainer instrument , and assessment of quality of life of the patients using HRQL questionnaire (SF-36) before and after the treatment sessions.

NCT ID: NCT04457531 Recruiting - Clinical trials for Diabetic Peripheral Neuropathy

LiuWeiLuoBi Granule for the Treatment of Diabetic Peripheral Neuropathy

Start date: October 26, 2020
Phase: Early Phase 1
Study type: Interventional

Based on network pharmacology, Liuweiluobi Granule was screened to treat diabetes peripheral neuropathy with deficiency of the spleen and kidney and stasis-heat syndrome.In the preliminary animal experiment, it suggested that this granule had a significant protective effect on the peripheral motor nerves of diabetic peripheral neuropathy and the effect of anti-inflammation, and the prescription did not induce the death of zebrafish at a concentration of 1000 ug/mL, without any obvious toxicity. This study aims to evaluate the efficacy of Liuweiluobi Granule in improving neurotransmission function in patients with diabetic peripheral neuropathy through a pilot, randomized controlled study.

NCT ID: NCT04455633 Completed - Diabetes Clinical Trials

Efficacy, Safety, and PK of LX9211 in Patients With Diabetic Peripheral Neuropathic Pain

RELIEF-DPN 1
Start date: July 7, 2020
Phase: Phase 2
Study type: Interventional

Evaluation of the efficacy of a low and high dose of LX9211 compared to placebo in reducing pain related to diabetic peripheral neuropathy over an 11 week assessment period.

NCT ID: NCT04453618 Not yet recruiting - Clinical trials for Diabetic Peripheral Neuropathy

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Food Effect of SYHA1402 in Healthy Subjects

Start date: August 2020
Phase: Phase 1
Study type: Interventional

A Multiple Doses Study to Evaluate the Safety, Tolerability, Pharmacokinetics (Including Food Effect) of SYHA1402 in Healthy Subjects.

NCT ID: NCT04440839 Completed - Clinical trials for Peripheral Arterial Disease

Implementation of Telemedicine for Patient With Lower Extremity Wounds

Start date: March 1, 2020
Phase: N/A
Study type: Interventional

The objective of this study is to determine if patients with lower extremity wounds in rural communities who undergo specialty referral through telemedicine have expedited care compared to patients who are treated through standard in person referral.